Table 4.
Compd | Activity IC50 nM |
Confonc | Fit valued | ||||
---|---|---|---|---|---|---|---|
Hypo2 | Hypo 4 | Hypo 7 | Hypo9 | Hypo10 | |||
3 | 0.009a | 59 | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 |
4 | 2.33a | 47 | 5.4 | 4.8 | 5.8 | 5.8 | 5.8 |
5 | 2.0a | 69 | 6.4 | 5.5 | 5.3 | 5.3 | 5.3 |
6 | 5.84a | 55 | 5.4 | 5.2 | 6.1 | 6.3 | 6.4 |
7 | 0.05a | 35 | 4.9 | 4.7 | 5.5 | 5.5 | 5.3 |
2 | 14.4b | 249 | 6.7 | - | - | - | - |
In vitro inhibition of ATRA metabolism by Hamster liver assay [48],
A biochemical assay was performed using microsomal preparations from T47D cells induced to express CYP26 [65].
A diverse set of conformations for all molecules were generated by using ‘Best conformer generation’ option with 20 kcal/mol energy cutoff [67],
Compare fit analysis of all compounds with maximum omitting feature value as 1.